132P The potential of VEGF-A in the peripheral blood serum as a biomarker of response in the addition of bevacizumab with chemotherapy-combined immunotherapy for metastatic nonsquamous non-small cell lung cancer
| Autor: | Sugisaka, J., Tanaka, K., Shiraishi, Y., Watanabe, Y., Daga, H., Azuma, K., Nishino, K., Mori, M., Terashima, M., Saito, H., Hata, A., Sakaguchi, T., Kozuki, T., Yamamoto, N., Nakagawa, K., Okamoto, I. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S268-S269 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|